HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1751557Generated: October 28, 2026
HCID 69675210, compound → HCID 69675130, compound
https://huagongshe.com/reaction/1751557
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 69675210 | HCID 69675210 | — |
| Reactant | HCID 131733626 | HCID 131733626 | — |
| Product | HCID 69675130 | HCID 69675130 | — |
Reaction Steps
The title compound was prepared according to the method employed to prepare (S)-1-((S)-8-(5-(4-(6-(2-((S)-1-((R)-2-(methoxycarbonylamino)-2-phenylacetyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)naphthalen-2-yl)phenyl)-1H-imidazol-2-yl)-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl)-3-methyl-1-oxobutan-2-ylcarbamic acid methyl ester, except that methyl (S)-1-((S)-2-(5-(9,9-difluoro-7-(2-((S)-pyrrolidin-2-yl)-1H-benzo[d]imidazol-6-yl)-9H-fluoren-2-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-ylcarbamate 3HCl salt was used instead of methyl (S)-3-methyl-1-oxo-1-((S)-8-(5-(4-(6-(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)naphthalen-2-yl)phenyl)-1H-imidazol-2-yl)-1,4-dioxa-7-azaspiro[4.4]nonan-7-yl)butan-2-ylcarbamate 3HCl salt. MS (ESI) m/z 872.50 [M+H]+. (97.5 mg, 59%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09156823B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-db55585da3d544b39d0e0994030838aa |
|---|
| Source note | uspto-grants-2015_10 |
|---|